Advisor Group, Inc. - CASI PHARMACEUTICALS INC ownership

CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 45 filers reported holding CASI PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Advisor Group, Inc. ownership history of CASI PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$09
-90.0%
0.00%
Q4 2018$0900.0%0.00%
Q3 2018$0
-100.0%
900.0%0.00%
Q2 2018$1,000900.0%0.00%
Q1 2018$0900.0%0.00%
Q4 2017$0900.0%0.00%
Q3 2017$0900.0%0.00%
Q2 2017$090
-30.8%
0.00%
Q1 2017$01300.0%0.00%
Q4 2016$01300.0%0.00%
Q3 2016$01300.0%0.00%
Q2 2016$01300.00%
Other shareholders
CASI PHARMACEUTICALS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Wellington Shields & Co., LLC 951,064$7,827,0004.06%
Wellington Shields Capital Management, LLC 855,056$7,037,0001.16%
Manatuck Hill Partners, LLC 15,090$124,0000.05%
Moors & Cabot, Inc. 22,935$187,0000.02%
Perceptive Advisors 43,682$360,0000.01%
ROYCE & ASSOCIATES LP 120,000$988,0000.01%
ALPS ADVISORS INC 125,015$1,029,0000.01%
MetLife Investment Management, LLC 26,316$217,0000.00%
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 136,518$1,124,0000.00%
Private Advisor Group, LLC 15,001$122,0000.00%
View complete list of CASI PHARMACEUTICALS INC shareholders